Mr. Boyle serves as Vice President of Investor Relations at Arvinas. Mr. Boyle is responsible for leading our investor relations strategy and liaising with the investor community, including sell-side and buy-side analysts, industry analysts, and investors worldwide. Prior to joining Arvinas, Mr. Boyle spent nearly five years at Sage Therapeutics, where he led the development and execution of an integrated investor relations and communications strategy, most recently as Vice President of Investor Relations. With more than 15 years of experience in investor relations and communications within the biotechnology industry, he increased responsibility at BIND Therapeutics and Biogen. Mr. Boyle received a B.A. in Finance from the University of Colorado.